See also this year's filing and all EDGAR filings for this company.
PDF Report 0001582313_2017_Xenon_Pharmaceuticals_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001582313, Xenon Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 65,675,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,404,000 |
| 3 | remainder_Assets | 408,000 |
| 4 | LiabilitiesCurrent | 3,516,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 70,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,792,000 |
| 9 | ResearchAndDevelopmentExpense | 19,828,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,803,000 |
| 12 | remainder_NetIncome | 1,820,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 67,487,000 |
| 1 | Liabilities | 3,586,000 |
| 2 | Expenses | 26,620,000 |
| 3 | Revenues | 1,803,000 |
| 4 | StockholdersEquity | 63,901,000 |
| 5 | NetIncome | -22,997,000 |
| 6 | ComprehensiveNetIncome | -22,997,000 |
| 7 | BaseVar | 50,658,000 |
| 8 | EconomicCapitalRatio | 2.45 |
Edgar->Model Mapping
Feature Distribution
